Data & ReproClinical MedicineFreedomIntelligence/OpenClaw-Medical-SkillsData & Reproduction
NK

nk-cell-therapy-agent

Maintainer FreedomIntelligence · Last updated April 1, 2026

NK cell therapy design: receptor engineering, expansion protocols, persistence.

OpenClawNanoClawAnalysisReproductionnk-cell-therapy-agent🧠 bioos extended suiteimmunology & cell therapynk

Original source

FreedomIntelligence/OpenClaw-Medical-Skills

https://github.com/FreedomIntelligence/OpenClaw-Medical-Skills/tree/main/skills/nk-cell-therapy-agent

Maintainer
FreedomIntelligence
License
MIT
Last updated
April 1, 2026

Skill Snapshot

Key Details From SKILL.md

2 min

Key Notes

  • The NK Cell Therapy Agent provides AI-driven design and optimization of natural killer cell therapies for cancer treatment. It covers CAR-NK engineering, cytokine-induced memory-like (CIML) NK generation, KIR/HLA matching, and NK cell expansion optimization.
  • When designing CAR-NK constructs for tumor targeting.
  • To optimize KIR/HLA mismatch for allogeneic NK therapy.
  • For generating memory-like NK cells with enhanced persistence.
  • When predicting NK cell activation against specific tumor types.

Source Doc

Excerpt From SKILL.md

Core Capabilities

  1. CAR-NK Design: Design chimeric antigen receptors optimized for NK cell biology (NK-specific signaling domains).

  2. KIR/HLA Matching: Predict KIR-HLA interactions for donor selection in allogeneic therapy.

  3. Memory-Like NK Generation: Optimize CIML protocol with IL-12/15/18 cytokine preactivation.

  4. Expansion Optimization: ML models for feeder-free NK expansion conditions.

  5. Tumor Target Prediction: Match NK receptor profiles to tumor ligand expression.

  6. Persistence Enhancement: Engineering strategies for improved in vivo survival.

NK Cell Advantages Over T Cells

FeatureNK CellsT Cells
MHC requirementNoYes
Allogeneic useYes (no GVHD)Limited (GVHD risk)
CRS riskLowerHigher
Off-the-shelfYesAutologous typical
Antigen escapeMultiple receptorsSingle CAR
PersistenceShorterLonger

Workflow

  1. Input: Target antigen, tumor type, NK source (PB, UCB, iPSC, cell line).

  2. CAR Design: Generate optimized CAR-NK construct sequence.

  3. KIR Analysis: Determine KIR genotype and HLA matching for donors.

  4. Activation Protocol: Optimize cytokine cocktail for desired phenotype.

  5. Expansion: Design feeder-based or feeder-free expansion protocol.

  6. Quality Prediction: Predict NK product functionality.

  7. Output: CAR sequence, donor recommendations, expansion protocol, QC metrics.

Use cases

  • When designing CAR-NK constructs for tumor targeting.

Not for

  • Do not rely on this catalog entry alone for installation or maintenance details.

Upstream Related Skills

  • CART_Design_Optimizer_Agent - For CAR engineering principles
  • Epitope_Prediction_Agent - For target selection
  • Flow_Cytometry_AI - For NK phenotyping

Related skills

Related skills

Back to directory
AR
Data & ReproClinical Medicine

armored-cart-design-agent

Design armored CAR-T cells with cytokine payloads and resistance mechanisms.

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView
AR
Data & ReproClinical Medicine

arxiv-search

Search arXiv physics, math, and computer science preprints using natural language queries. Powered by Valyu semantic search.

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView
AU
Data & ReproClinical Medicine

autonomous-oncology-agent

Autonomous oncology research agent: literature mining, trial matching, biomarker analysis, and treatment hypothesis generation.

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView
BI
Data & ReproClinical Medicine

bio-cfdna-preprocessing

Preprocesses cell-free DNA sequencing data including adapter trimming, alignment optimized for short fragments, and UMI-aware duplicate remo…

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView